143 related articles for article (PubMed ID: 1165143)
1. Pharmacological approaches to the treatment of morphine-type dependence.
Halbach H
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):6-12. PubMed ID: 1165143
[TBL] [Abstract][Full Text] [Related]
2. Narcotic antagonists in the treatment of opiate dependence.
Fink M; Zaks A; Resnick RB; Freedman AM
Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728
[No Abstract] [Full Text] [Related]
3. [Management of opium addicts using opiates and their antagonists].
Burchard JM
Nervenarzt; 1972 Oct; 43(10):501-4. PubMed ID: 4564819
[No Abstract] [Full Text] [Related]
4. Blockade with methadone, cyclazocine, and naloxone.
Freedman AM; Zaks A; Resnick R; Fink M
Int J Addict; 1970 Sep; 5(3):507-15. PubMed ID: 5524385
[No Abstract] [Full Text] [Related]
5. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
6. Cyclazocine in the treatment of narcotic addiction.
Jaffe JH
Curr Psychiatr Ther; 1967; 7():147-56. PubMed ID: 4860298
[No Abstract] [Full Text] [Related]
7. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
Fraser HF
Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198
[No Abstract] [Full Text] [Related]
8. [Morphine intoxication and abstinence].
Anggård E
Lakartidningen; 1977 Nov; 74(48):4305-9. PubMed ID: 592916
[No Abstract] [Full Text] [Related]
9. Buprenorphine and naloxone interactions in methadone maintenance patients.
Mendelson J; Jones RT; Welm S; Brown J; Batki SL
Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological adjuncts in the treatment of opiate dependence.
Resnick RB
Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
[No Abstract] [Full Text] [Related]
11. Synthetic 14-hydroxymorphinan narcotic antagonists.
Pachter IJ
Adv Biochem Psychopharmacol; 1973; 8(0):57-62. PubMed ID: 4153098
[No Abstract] [Full Text] [Related]
12. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
13. [Fractionated opiate withdrawal with tiapride and naloxone, a new treatment approach].
Presslich O; Loimer N; Aschauer G; Fodor G; Pfersmann D; Müller K; Pakesch G; Lieber A
Psychiatr Prax; 1989 Sep; 16(5):179-81. PubMed ID: 2798589
[TBL] [Abstract][Full Text] [Related]
14. Addiction and the community. (Narcotic substitution therapy).
Taylor WJ; Chambers CD; Bowling CE
Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
[No Abstract] [Full Text] [Related]
15. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
Belozertseva IV; Andreev BV
Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
17. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
19. Effects of narcotic agonists and antagonists on schedule-induced water and morphine ingestion.
Leander JD; McMillan DE; Harris LS
J Pharmacol Exp Ther; 1975 Nov; 195(2):271-8. PubMed ID: 1237618
[TBL] [Abstract][Full Text] [Related]
20. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
Gmerek DE; Dykstra LA; Woods JH
J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
